Jpmorgan Chase & CO Lemaitre Vascular Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 173,536 shares of LMAT stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173,536
Previous 147,489
17.66%
Holding current value
$14.8 Million
Previous $13.6 Million
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding LMAT
# of Institutions
296Shares Held
21.6MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.48MShares$297 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.6MShares$137 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.6MShares$137 Million0.0% of portfolio
-
Copeland Capital Management, LLC990KShares$84.5 Million1.74% of portfolio
-
Geneva Capital Management LLC915KShares$78.1 Million1.3% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $1.87B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...